CIEL group to hit capital market by first half of 2024
时间:2024-06-26 13:14:57 阅读(143)
The Initial Public Offering of human resources solutions provider CIEL Group is expected in the first half of 2024.
The city-based company has ‘rigorously’ invested in optimizing the HR processes with digital intervention, said CIEL Group Executive Chairperson and Director K Pandiarajan on Tuesday.
“I take pride in announcing that CIEL has rigorously invested in optimizing HR processes with digital intervention,” he told reporters.
The IPO would help in strengthening these plans, positioning CIEL as the leading HR services provider, offering seamless end-to-end HR solutions, he added.
The upcoming IPO is expected to enable CIEL to support its technology investments for digital assets and team expansion apart from pursuing the trajectory of inorganic growth.
On the job market expected during the second half of the year, in a statement, CIEL Group said the recruitment activities in information technology, outsourcing, and startups are expected to pick up in January-March 2024.
Bright spots can be witnessed in Banking, financial services, and insurance (BFSI), electric vehicles, healthcare, and telecom sectors.
According to the company, employment in Tier II and III cities is expected to grow faster than that in the metros backed by the growth of the internet and shifting consumer spending towards online shopping.
猜你喜欢
- Crude oil prices slip as concerns over rate hikes rattle investors
- Bitcoin holds drop as traders mull likely reaction to spot ETFs
- Crude worst performing asset class, wait for signs of reversal before investing
- Markets Wrap Up – 8 December- Stocks rise, rupee falls; Asia, Europe markets, Gold, Crude, Crypto updates
- Markets undergoing correction for past month, select heavyweights outperform; US markets to drive global cues
- Bourses to set common price for stocks on listing day
- Congress’ Sunil Kedar disqualified from Maharashtra assembly after conviction in bank scam
- Merrill Lynch Fund offloads HDFC Bank shares for Rs 51 crore
- Biocon, Elin, KfinTech, Gland Pharma among 28 NSE stocks to hit 52-week lows, 30 rise to 52-week highs